I am pleased to join Oncotarget as an Editor-in-Chief this June, 2024.
This is a great journal that was started in 2010. The journal has published impactful research over the years by leaders in the field. The journal is indexed in PubMed, PMC, and MEDLINE and has its own digital archive. Oncotarget follows the guidelines based on the recommendations of the Committee on Publication Ethics (COPE). The journal conducts author interviews and promotes published research through press releases. https://lnkd.in/e3pnxfQr https://lnkd.in/eJ63zVeM https://lnkd.in/e7PeqzKF https://lnkd.in/eFyTKPGK
I’d like to invite my colleagues to submit manuscripts and would particularly encourage translational research, progress in precision oncology, therapy for cancer’s hallmarks, drug resistance, plasticity, epigenetics, microbiome, environmental carcinogenesis, intersection of behavior and biology of cancer, cancer immunotherapy, functional precision medicine, molecular imaging, theranostics, stem cells, liquid biopsy and tumor heterogeneity.
Problems such as CNS primary or metastatic cancers, blood brain barrier research, viruses and cancer, cell cycle and cell death, biomarkers (predictive, prognostic, and pharmacodynamic), pro-drugs, nanotherapeutics, drug metabolism, novel omics, tumor dormancy and early detection are of interest.
Technology enabling of progress using AI, statistics and novel clinical trial designs, new devices for diagnostics and therapeutics, single cell profiling, 3-D visualization of TME, single molecule visualization are relevant areas of interest.
We welcome clinical case reports, case series, commentaries, reviews, clinical trial results, and Meeting Reports.
Please feel free to reach out to me directly if you have any questions or manuscripts we might consider.
I hope you will have a positive experience in sharing your contributions of new knowledge and/or expertise in an efficient manner with Oncotarget.
Working for global oncology and research integrity. Fascinated by ovarian cancer and biomarkers. Columnist for @ASCO | #LINO23 Alumnus | 2023 African Cancer Leaders Institute Fellow | ASCO IDEA 2024 Awardee
A lot of research integrity concerns in this journal as well!
Working for global oncology and research integrity. Fascinated by ovarian cancer and biomarkers. Columnist for @ASCO | #LINO23 Alumnus | 2023 African Cancer Leaders Institute Fellow | ASCO IDEA 2024 Awardee
Associate Dean for Oncologic Sciences, Warren Alpert Medical School, Brown University, Providence, RI
Khalid El Bairi this is from at least 6 years ago while the journal was competing with other top journals. I believe the journal was maliciously targeted at the time and has put this behind them. It is fully listed at present after fighting back. I said to communicate current concerns.
Working for global oncology and research integrity. Fascinated by ovarian cancer and biomarkers. Columnist for @ASCO | #LINO23 Alumnus | 2023 African Cancer Leaders Institute Fellow | ASCO IDEA 2024 Awardee
Does Oncotarget waives the APCs for authors from LMICs ? Thanks
Congratulations on joining Oncotarget as the Editor-in-Chief, Dr. El-Deiry! I wish you great success in this new role and look forward to the valuable contributions you and your team will bring to the field.
Clinical Research Solutions Strategist | Doctoral Researcher
Congratulations Wafik - I’m especially interested in the AI and translation research space(s) - and have thought provoking data regarding pancreatic cancer with brain metastasis - co-developed with my colleagues Dr. Susan H. and Derek Cridebring, PhD. Will be in touch
Co-Founder & Advisory Board at Regenerative Medicine Solutions
Congratulations Wafik. Good & traditionally independent scientific medical journal. Your experienced opinion and expertise will no doubt help it to become even better.
Cellular and Molecular Biologist #PhD|Veterinary Clinical #Biochemist #DVM I Human #ProstateCancer 3D #Organoid and 2D #celllines | #Androgenreceptor biology |Trained in #Diverse Disciplines
Scientist: Apollo Hospitals Educational and Research Foundation| Founding member: Indian Extracellular Vesicles Society| Author: Scientific | Youtuber: Health Care|
GCC Distinguished Cancer Scholar, Professor and Director, Cancer Biology Program, Department of OB/GYN, Morehouse School of Medicine, Atlanta, Ga 30310